ArticleThe Journal of experimental medicine2025

JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLL.

Shifa Khaja Saleem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.